Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Indoco Remedies Limited
WARNING LETTER
•Indoco Remedies Limited•January 25, 2019

Indoco Remedies Limited – FDA Warning Letter, Jan 25, 2019

Record Details

The FDA issued a Warning Letter to Indoco Remedies Limited (Plant I) in Goa, India, following an inspection from January 17-25, 2019, citing significant violations of current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Incomplete Batch Production Records (21 CFR 211.188):** Compression machine process control values (e.g., compression force, filling depth, automatic weight control) were inadequately reported in batch records for tablets intended for the U.S. market. Handwritten values often differed significantly from electronic data recorded by the programmable logic controller (PLC), with the quality unit releasing batches based on deficient records. Previous inspections also noted similar discrepancies. The firm's response was deemed insufficient for not committing to a comprehensive retrospective data integrity evaluation or adequately detailing process control procedures. 2. **Inadequate Investigation of Discrepancies (21 CFR 211.192):** The investigation into batch record discrepancies for tablets was insufficient, lacking a thorough root cause analysis for high variability in process parameters and failing to assess the impact of atypical values on batch quality. The firm acknowledged staff believed it was acceptable to overlook aberrant equipment control values if key tablet attributes were within specification. 3. **Incomplete Laboratory Records (21 CFR 211.194(a)):** The

Company
Indoco Remedies Limited
Inspection date
January 25, 2019
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 36064184-0cc5-480f-bb1b-f0630c35a051

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.18821 CFR 211.19221 CFR 211.194(a)21 CFR 211.34FD&C Act 801(a)(3)FD&C Act 501(a)(2)(B)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Indoco Remedies Limited
  • 483 - 2026-09-04September 4, 2026
  • WARNING_LETTER - 2024-07-26July 26, 2024
  • 483 - 2024-07-26July 26, 2024
  • 483 - 2023-02-28February 28, 2023
  • 483 - 2019-06-04June 4, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Indoco Remedies Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.